Daily cost of delay to adequate antibiotic treatment among patients surviving a hospitalization with community-onset Acinetobacter baumannii pneumonia or sepsis
Crossref DOI link: https://doi.org/10.1186/s13054-017-1719-9
Published Online: 2017-06-05
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zilberberg, Marya D.
Nathanson, Brian H.
Sulham, Kate
Fan, Weihong
Shorr, Andrew F.
Funding for this research was provided by:
The Medicines Company (NA, NA)